Filing Details
- Accession Number:
- 0001641172-25-012539
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-27 17:56:53
- Reporting Period:
- 2025-05-27
- Filing Date:
- 2025-05-27
- Accepted Time:
- 2025-05-27 17:56:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1958777 | Fibrobiologics Inc. | FBLG | Pharmaceutical Preparations (2834) | 863329066 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2010662 | Hamid Khoja | C/O Fibrobiologics, Inc. 455 E. Medical Center Blvd., Suite 300 Houston, TX 77598 | Chief Scientific Officer | No | Yes | No | No |
Transaction Summary
| Purchased: | 20,000 shares | Avg. Price: $0.84 | Total Value: $16,800.00 |
| Number of Shares After Transactions: | 31,250 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-27 | 20,000 | $0.84 | 31,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
